Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Faivre-Finn

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
The British Journal of Radiology|July 8, 2015
Stereotactic body radiotherapy for central lung tumours: Author replyS Adebahr, S Collette, E Shash, et al.
ESMO Open|March 5, 2022
Outcomes with durvalumab after chemoradiotherapy in stage IIIA-N2 non-small-cell lung cancer: an exploratory analysis from the PACIFIC trialS Senan, M Özgüroğlu, D Daniel, et al.
The British Journal of Radiology|April 16, 2015
LungTech, an EORTC Phase II trial of stereotactic body radiotherapy for centrally located lung tumours: a clinical perspectiveS Adebahr, S Collette, E Shash, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 9, 2010
Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01)C Le Péchoux, A Laplanche, C Faivre-Finn, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 15, 2020
Reduced Fractionation in Lung Cancer Patients Treated with Curative-intent Radiotherapy during the COVID-19 PandemicC Faivre-Finn, J D Fenwick, K N Franks, et al.
The European Respiratory Journal|July 2, 2009
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)A Brunelli, A Charloux, C T Bolliger, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 10, 2022
Can Real-world Data and Rapid Learning Drive Improvements in Lung Cancer Survival? The RAPID-RT StudyG Price, S Devaney, D P French, et al.
BMJ Open|January 29, 2016
Protocol for PIT: a phase III trial of prophylactic irradiation of tracts in patients with malignant pleural mesothelioma following invasive chest wall interventionN Bayman, D Ardron, L Ashcroft, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 17, 2021
Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>☆</sup>A-M C Dingemans, M Früh, A Ardizzoni, et al.
Journal of Medical Imaging and Radiation Sciences|August 17, 2024
Simultaneous implementation of unrelated tumour sites on the MR Linac: A review of the commissioning process from a radiographer perspective and lessons learnedA Clough, E Pitt, C Nelder, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
The British Journal of Radiology|July 8, 2015
Stereotactic body radiotherapy for central lung tumours: Author replyS Adebahr, S Collette, E Shash, et al.
ESMO Open|March 5, 2022
Outcomes with durvalumab after chemoradiotherapy in stage IIIA-N2 non-small-cell lung cancer: an exploratory analysis from the PACIFIC trialS Senan, M Özgüroğlu, D Daniel, et al.
The British Journal of Radiology|April 16, 2015
LungTech, an EORTC Phase II trial of stereotactic body radiotherapy for centrally located lung tumours: a clinical perspectiveS Adebahr, S Collette, E Shash, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 9, 2010
Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01)C Le Péchoux, A Laplanche, C Faivre-Finn, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 15, 2020
Reduced Fractionation in Lung Cancer Patients Treated with Curative-intent Radiotherapy during the COVID-19 PandemicC Faivre-Finn, J D Fenwick, K N Franks, et al.
The European Respiratory Journal|July 2, 2009
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)A Brunelli, A Charloux, C T Bolliger, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 10, 2022
Can Real-world Data and Rapid Learning Drive Improvements in Lung Cancer Survival? The RAPID-RT StudyG Price, S Devaney, D P French, et al.
BMJ Open|January 29, 2016
Protocol for PIT: a phase III trial of prophylactic irradiation of tracts in patients with malignant pleural mesothelioma following invasive chest wall interventionN Bayman, D Ardron, L Ashcroft, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 17, 2021
Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>☆</sup>A-M C Dingemans, M Früh, A Ardizzoni, et al.
Journal of Medical Imaging and Radiation Sciences|August 17, 2024
Simultaneous implementation of unrelated tumour sites on the MR Linac: A review of the commissioning process from a radiographer perspective and lessons learnedA Clough, E Pitt, C Nelder, et al.
Pageof 9